Moon Kyoo Jang
Rank 75 by 10-year citations to CLAD papers (24 papers, 410 citations). Role unknown; field: unknown.
As of . Primary source: ORCID record.
Summary
Moon Kyoo Jang. Role: unknown. No source read in this review states the role of this author. Field: unknown. Affiliation: unknown (marked missing). Basis: unverified; OpenAlex lists "National Heart, Lung, and Blood Institute" on the most recent corpus paper (2026). Not confirmed as current.. Counts in the OpenAlex corpus (retrieved 2026-10-10): 24 papers and 410 citations over ten years; 1 first-author and 0 last-author papers. Ranks: main 75, excluding consensus papers 61, first or last author 428. The method is stated once on the People list page. Linked papers are the most-cited corpus papers of this author.
Citation ranks (10 years)
| Main rank | Rank excluding consensus papers | Rank by first or last author papers |
|---|---|---|
| 75 of 800 | 61 of 794 | 428 of 512 |
Citations: 410 in total, 410 excluding consensus and guideline papers (0 of this author's papers excluded), 1 on first or last author papers (1 first, 0 last).
Ranking method: see the methodology note at the top of the People list and the full methodology document.
Role and field
- Role
- unknown
- Role status
- unknown (no source read in this review states the role)
- Field
- unknown
- Field basis
- no unit name found in the sources read
Only what a cited source supports is stated. Entries marked self-asserted come from the person's own ORCID record. The field is taken from the name of the unit, not inferred from the person's name.
Details
- papers 10y
- 24
- fractional papers 10y
- 1.61
- citations 10y
- 410
- fractional citations 10y
- 21.3
- ranking retrieved
- 2026-10-10
- orcid
- 0000-0002-1657-2877
- openalex author id
- A5091075601
- merged open alex profiles
- 3
- affiliation basis
- unverified; OpenAlex lists "National Heart, Lung, and Blood Institute" on the most recent corpus paper (2026). Not confirmed as current.
- papers excluding consensus 10y
- 24
- citations excluding consensus 10y
- 410
- consensus papers excluded 10y
- 0
- first author papers 10y
- 1
- last author papers 10y
- 0
- lead author citations 10y
- 1
- lead author papers 10y
- 1
Sources and links
- ORCID record (primary)
- OpenAlex author profile (ranking source)
- Most-cited CLAD paper in corpus: Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD) (The Journal of Heart and Lung Transplantation, 2021); 55 citations; DOI 10.1016/j.healun.2021.02.008
- Most-cited CLAD paper in corpus: Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death (American Journal of Transplantation, 2023); 27 citations; DOI 10.1016/j.ajt.2022.12.019
- Most-cited CLAD paper in corpus: Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease (The Journal of Heart and Lung Transplantation, 2024); 16 citations; DOI 10.1016/j.healun.2024.04.064
- Most-cited CLAD paper in corpus: Donor–derived cell-free DNA associated with increased risk of chronic lung allograft dysfunction and mortality: Are absolute levels better than percentage? (The Journal of Heart and Lung Transplantation, 2026); 9 citations; DOI 10.1016/j.healun.2026.01.022
- Most-cited CLAD paper in corpus: Restrictive Allograft Syndrome Patients Have Higher Cell-Free DNA Assessed Allograft Injury Prior to Diagnosis (The Journal of Heart and Lung Transplantation, 2022); 3 citations; DOI 10.1016/j.healun.2022.01.043
Known gaps in this record
- role or job title
- centre membership relation (not asserted)
- funding and conflicts of interest
- verified current affiliation
- only the top-30 entries were checked by hand for ID merges and splits
Information resource only. Not medical advice. Not a substitute for the care of the patient's transplant team.